Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-25

Clinical Trial Update: Effect of Carnitine on Uremic Cardiomyopathy [NA]

View source ↗

Summary

A completed clinical trial evaluated the effect of carnitine on uremic cardiomyopathy; the listed condition is Disorder of Fatty Acid Metabolism and the sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carnitine (L-carnitine)

Snippet

Sponsor: Toujinkai Hospital | Conditions: Disorder of Fatty Acid Metabolism | NA | Status: COMPLETED